Colorectal Cancer Not MSI-H or MMR-deficient

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Colorectal Cancer Not MSI-H or MMR-deficient trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownPhase 1/2

NCT03475953

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Assessment of the efficacy and safety of Regorafenib and Avelumab in patients with advanced or metastatic solid tumors (ten cohorts), once the Recommanded Phase…

France747 participantsStarted 2018-05-04

Treatment: Phase 1 : Regorafenib, Phase 1 : Avelumab